Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Subbu Nambi is an analyst at Guggenheim. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 03/28/2025
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 02/25/2025 | VCYT | Buy Now | Veracyte | $31.10 | 44.69% | Subbu Nambi44% | $45 → $45 | Reiterates | Buy → Buy | Get Alert |
| 02/25/2025 | TEM | Buy Now | Tempus AI | $51.62 | — | Subbu Nambi44% | — | Reiterates | Buy → Buy | Get Alert |
| 02/24/2025 | BRKR | Buy Now | Bruker | $43.54 | — | Subbu Nambi44% | — | Reiterates | Buy → Buy | Get Alert |
| 02/24/2025 | GH | Buy Now | Guardant Health | $45.00 | 24.44% | Subbu Nambi44% | $56 → $56 | Reiterates | Buy → Buy | Get Alert |
| 02/07/2025 | ILMN | Buy Now | Illumina | $82.28 | 82.3% | Subbu Nambi44% | $170 → $150 | Maintains | Buy | Get Alert |
| 01/22/2025 | GH | Buy Now | Guardant Health | $45.00 | — | Subbu Nambi44% | — | Reiterates | Buy → Buy | Get Alert |
| 01/17/2025 | BRKR | Buy Now | Bruker | $43.54 | — | Subbu Nambi44% | — | Reiterates | Buy → Buy | Get Alert |
| 01/17/2025 | NTRA | Buy Now | Natera | $148.30 | 34.86% | Subbu Nambi44% | $170 → $200 | Maintains | Buy | Get Alert |
| 12/19/2024 | NEOG | Buy Now | Neogen | $9.31 | 61.09% | Subbu Nambi44% | → $15 | Initiates | → Buy | Get Alert |
| 12/19/2024 | BRKR | Buy Now | Bruker | $43.54 | 65.37% | Subbu Nambi44% | → $72 | Initiates | → Buy | Get Alert |
| 12/09/2024 | TEM | Buy Now | Tempus AI | $51.62 | 43.36% | Subbu Nambi44% | → $74 | Initiates | → Buy | Get Alert |
| 10/17/2024 | GRAL | Buy Now | GRAIL | $29.00 | — | Subbu Nambi44% | — | Initiates | → Neutral | Get Alert |
| 10/10/2024 | VCYT | Buy Now | Veracyte | $31.10 | 28.62% | Subbu Nambi44% | → $40 | Initiates | → Buy | Get Alert |
| 06/28/2024 | GH | Buy Now | Guardant Health | $45.00 | -20% | Subbu Nambi44% | → $36 | Upgrade | Neutral → Buy | Get Alert |
| 06/27/2024 | SOPH | Buy Now | Sophia Genetics | $3.73 | 60.86% | Subbu Nambi44% | → $6 | Initiates | → Buy | Get Alert |
| 06/27/2024 | NAUT | Buy Now | Nautilus Biotechnology | $0.94 | 540.48% | Subbu Nambi44% | → $6 | Initiates | → Buy | Get Alert |
| 06/26/2024 | TXG | Buy Now | 10x Genomics | $9.47 | — | Subbu Nambi44% | — | Downgrade | Buy → Neutral | Get Alert |
| 06/25/2024 | TXG | Buy Now | 10x Genomics | $9.47 | — | Subbu Nambi44% | — | Downgrade | Buy → Neutral | Get Alert |
| 06/18/2024 | RGEN | Buy Now | Repligen | $136.90 | — | Subbu Nambi44% | — | Initiates | → Neutral | Get Alert |
| 06/05/2024 | TWST | Buy Now | Twist Bioscience | $40.40 | 31.19% | Subbu Nambi44% | → $53 | Initiates | → Buy | Get Alert |
| 04/05/2024 | GH | Buy Now | Guardant Health | $45.00 | — | Subbu Nambi44% | — | Reiterates | → Neutral | Get Alert |
| 12/14/2023 | CSTL | Buy Now | Castle Biosciences | $20.10 | 24.38% | Subbu Nambi44% | → $25 | Initiates | → Buy | Get Alert |
| 12/14/2023 | MYGN | Buy Now | Myriad Genetics | $10.10 | 127.72% | Subbu Nambi44% | → $23 | Initiates | → Buy | Get Alert |
| 12/14/2023 | GH | Buy Now | Guardant Health | $45.00 | — | Subbu Nambi44% | — | Initiates | → Neutral | Get Alert |
| 12/14/2023 | NTRA | Buy Now | Natera | $148.30 | -52.8% | Subbu Nambi44% | → $70 | Initiates | → Buy | Get Alert |
| 12/14/2023 | EXAS | Buy Now | Exact Sciences | $44.99 | 100.04% | Subbu Nambi44% | → $90 | Initiates | → Buy | Get Alert |
| 12/14/2023 | PACB | Buy Now | Pacific Biosciences | $1.24 | — | Subbu Nambi44% | — | Initiates | → Neutral | Get Alert |
| 12/14/2023 | ILMN | Buy Now | Illumina | $82.28 | 88.38% | Subbu Nambi44% | → $155 | Initiates | → Buy | Get Alert |
| 12/14/2023 | AKYA | Buy Now | Akoya Biosciences | $1.49 | — | Subbu Nambi44% | — | Initiates | → Neutral | Get Alert |
| 12/14/2023 | TXG | Buy Now | 10x Genomics | $9.47 | 533.58% | Subbu Nambi44% | → $60 | Initiates | → Buy | Get Alert |
